Ugandan President Backs Bid to Tackle Fake Meds With Blockchain
Uganda's government is supporting a project using blockchain tech to fight the problem of counterfeit medicines.
Uganda's president is getting behind a project using blockchain tech to fight the problem of counterfeit medicines.
In an announcement on Monday, MediConnect – a firm that has built a solution to track and manage prescription meds using blockchain –said it has received "indicative" support from the Ugandan government to explore the use of its product in the country.
The news comes after the company met with the president of Uganda, Yoweri Museveni, as well as its Minister of Health, Dr Jane Ruth Aceng, and other government officials to discuss the benefits of a blockchain solution.
As well as pledging support for MediConnect’s solution in tackling the spread of fake drugs in Uganda, the government said it would be open to working with MediConnect on the issue, according to the press release.
MediConnect CEO Dexter Blackstock said:
“The Ugandan President, Minister of Health and National Drug Authority all understand the need to act fast to tackle the country’s counterfeit drug problem and recognise the benefits offered by tracing medication on the secure, scalable blockchain framework we are developing. We see this as an important opportunity for MediConnect to form part of Uganda’s national infrastructure and protect its citizens by ensuring all drugs in circulation are authentic and safe.”
The firm cited data from the Ugandan National Drug Authority as indicating that 10 percent of drugs prescribed in the country have below par or counterfeit copies sold on the market. The World Health Organization has also found that 10 percent of medical products in developing countries, many of which are in Africa, are substandard or fake.
At the meeting with government was also Uebert Angel, a founder of a Pentecostal ministry in the U.K. and strategic partner of MediConnect.
He said in the announcement:
President Museveni confirmed the meeting and government support on Twitter.
Medicines image via Shutterstock
The leader in news and information on cryptocurrency, digital assets and the future of money, CoinDesk is a media outlet that strives for the highest journalistic standards and abides by a strict set of editorial policies. CoinDesk is an independent operating subsidiary of Digital Currency Group, which invests in cryptocurrencies and blockchain startups. As part of their compensation, certain CoinDesk employees, including editorial employees, may receive exposure to DCG equity in the form of stock appreciation rights, which vest over a multi-year period. CoinDesk journalists are not allowed to purchase stock outright in DCG.
Learn more about Consensus 2023, CoinDesk’s longest-running and most influential event that brings together all sides of crypto, blockchain and Web3. Head to consensus.coindesk.com to register and buy your pass now.